Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
Kobayashi, Kazufumi; Ogasawara, Sadahisa; Maruta, Susumu; Okubo, Tomomi; Itokawa, Norio; Haga, Yuki; Seko, Yuya; Moriguchi, Michihisa; Watanabe, Shunji; Shiko, Yuki; Takatsuka, Hirokazu; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kiyono, Soichiro; Kanogawa, Naoya; Kondo, Takayuki; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Inaba, Yosuke; Ikeda, Masafumi; Okabe, Shinichiro; Morimoto, Naoki; Itoh, Yoshito; Nakamura, Kazuyoshi; Ito, Kenji; Azemoto, Ryosaku; Atsukawa, Masanori; Itobayashi, Ei; Kato, Naoya Share Save Share Save Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practiceNakagawa, Miyuki; Inoue, Masanori; Ogasawara, Sadahisa; Maruta, Susumu; Okubo, Tomomi; Itokawa, Norio; Iino, Yotaro; Obu, Masamichi; Haga, Yuki; Seki, Atsuyoshi; Kikuchi, Yasuharu; Kogure, Tadayoshi; Yumita, Sae; Ishino, Takamasa; Ogawa, Keita; Fujiwara, Kisako; Iwanaga, Terunao; Fujita, Naoto; Sakuma, Takafumi; Kojima, Ryuta; Kanzaki, Hiroaki; Koroki, Keisuke; Taida, Takashi; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakagawa, Ryo; Nakamoto, Shingo; Muroyama, Ryosuke; Chiba, Tetsuhiro; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Ito, Kenji; Mizumoto, Hideaki; Shinozaki, Masami; Kato, Jun; Kato, Naoya Share Save Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular CarcinomaKoroki, Keisuke; Kanogawa, Naoya; Maruta, Susumu; Ogasawara, Sadahisa; Iino, Yotaro; Obu, Masamichi; Okubo, Tomomi; Itokawa, Norio; Maeda, Takahiro; Inoue, Masanori; Haga, Yuki; Seki, Atsuyoshi; Okabe, Shinichiro; Koma, Yoshihiro; Azemoto, Ryosaku; Atsukawa, Masanori; Itobayashi, Ei; Ito, Kenji; Sugiura, Nobuyuki; Mizumoto, Hideaki; Unozawa, Hidemi; Iwanaga, Terunao; Sakuma, Takafumi; Fujita, Naoto; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Saito, Tomoko; Kondo, Takayuki; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Tawada, Akinobu; Chiba, Tetsuhiro; Arai, Makoto; Kanda, Tatsuo; Maruyama, Hitoshi; Kato, Jun; Kato, Naoya Share Save Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular CarcinomaMaruta, Susumu; Ogasawara, Sadahisa; Ooka, Yoshihiko; Obu, Masamichi; Inoue, Masanori; Itokawa, Norio; Haga, Yuki; Seki, Atsuyoshi; Okabe, Shinichiro; Azemoto, Ryosaku; Itobayashi, Ei; Atsukawa, Masanori; Sugiura, Nobuyuki; Mizumoto, Hideaki; Koroki, Keisuke; Kanayama, Kengo; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Saito, Tomoko; Kondo, Takayuki; Suzuki, Eiichiro; Nakamoto, Shingo; Tawada, Akinobu; Chiba, Tetsuhiro; Arai, Makoto; Kanda, Tatsuo; Maruyama, Hitoshi; Kato, Naoya Share Save Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in JapanOgasawara, Sadahisa; Ooka, Yoshihiko; Itokawa, Norio; Inoue, Masanori; Okabe, Shinichiro; Seki, Atsuyoshi; Haga, Yuki; Obu, Masamichi; Atsukawa, Masanori; Itobayashi, Ei; Mizumoto, Hideaki; Sugiura, Nobuyuki; Azemoto, Ryosaku; Kanayama, Kengo; Kanzaki, Hiroaki; Maruta, Susumu; Maeda, Takahiro; Kusakabe, Yuko; Yokoyama, Masayuki; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Saito, Tomoko; Suzuki, Eiichiro; Nakamoto, Shingo; Yasui, Shin; Tawada, Akinobu; Chiba, Tetsuhiro; Arai, Makoto; Kanda, Tatsuo; Maruyama, Hitoshi; Kato, Naoya Share Save The real world practice of systemic therapies in patients with advanced hepatocellular carcinoma in Japan: what has changed since lenvatinib approval?Maruta, Susumu; Ogasawara, Sadahisa; Ooka, Yoshihiko; Inoue, Masanori; Itokawa, Norio; Obu, Masamichi; Seki, Atsuyoshi; Haga, Yuki; Okabe, Shinichiro; Itobayashi, Ei; Atsukawa, Masanori; Azemoto, Ryosaku; Mizumoto, Hideaki; Sugiura, Nobuyuki; Maeda, Takahiro; Kobayashi, Kazufumi; Suzuki, Eiichiro; Nakamoto, Shingo; Yasui, Shin; Tawada, Akinobu; Chiba, Tetsuhiro; Arai, Makoto; Kanda, Tatsuo; Maruyama, Hitoshi; Kato, Naoya Share Save Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virusWin, Nan Nwe; Kanda, Tatsuo; Ogawa, Masahiro; Nakamoto, Shingo; Haga, Yuki; Sasaki, Reina; Nakamura, Masato; Wu, Shuang; Matsumoto, Naoki; Matsuoka, Shunichi; Kato, Naoya; Shirasawa, Hiroshi; Yokosuka, Osamu; Okamoto, Hiroaki; Moriyama, Mitsuhiko Share Save Case of lipoatrophic diabetes induced by juvenile dermatomyositisBaba, Yusuke; Kaneko, Hiyori; Takemoto, Minoru; Ide, Kana; Haga, Yuki; Kanda, Tatsuo; Akita, Shinsuke; Kubota, Yoshitaka; Kuroda, Masayuki; Kitagawa, Yutaka; Yokote, Koutaro Share Save Share Save Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus RibavirinKanda, Tatsuo; Nakamoto, Shingo; Sasaki, Reina; Nakamura, Masato; Yasui, Shin; Haga, Yuki; Ogasawara, Sadahisa; Tawada, Akinobu; Arai, Makoto; Mikami, Shigeru; Imazeki, Fumio; Yokosuka, Osamu Share Save Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in JapanKanda, Tatsuo; Yasui, Shin; Nakamura, Masato; Suzuki, Eiichiro; Arai, Makoto; Haga, Yuki; Sasaki, Reina; Wu, Shuang; Nakamoto, Shingo; Imazeki, Fumio; Yokosuka, Osamu Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
